Hypoxia Activates Notch4 via ERK/JNK/P38 MAPK Signaling Pathways to Promote Lung Adenocarcinoma Progression and Metastasis

Hypoxia contributes to the progression and metastasis of lung adenocarcinoma (LUAD). However, the specific underlying molecular mechanisms have not been fully elucidated. Here we report that Notch4 is upregulated in lung tissue from lung cancer patients. Functionally, Hypoxia activates the expressio...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cell and developmental biology Vol. 9; p. 780121
Main Authors Li, Xiaochen, Cao, Xiaopei, Zhao, Hanqiu, Guo, Mingzhou, Fang, Xiaoyu, Li, Ke, Qin, Lu, He, Yuanzhou, Liu, Xiansheng
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 20.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hypoxia contributes to the progression and metastasis of lung adenocarcinoma (LUAD). However, the specific underlying molecular mechanisms have not been fully elucidated. Here we report that Notch4 is upregulated in lung tissue from lung cancer patients. Functionally, Hypoxia activates the expressions of Delta-like 4 and Notch4, resulting in the excessive proliferation and migration of LUAD cells as well as apoptotic resistance. Notch4 silencing reduced ERK, JNK, and P38 activation. Meanwhile, Notch4 overexpression enhanced ERK, JNK, and P38 activation in LUAD cells. Furthermore, Notch4 exerted pro-proliferation, anti-apoptosis and pro-migration effects on LUAD cells that were partly reversed by the inhibitors of ERK, JNK, and p38. The binding interaction between Notch4 and ERK/JNK/P38 were confirmed by the co-immunoprecipitation assay. In vivo study revealed that Notch4 played a key role in the growth and metastasis of LUAD using two xenograft models. This study demonstrates that hypoxia activates Notch4-ERK/JNK/P38 MAPK signaling pathways to promote LUAD cell progression and metastasis.
AbstractList Hypoxia contributes to the progression and metastasis of lung adenocarcinoma (LUAD). However, the specific underlying molecular mechanisms have not been fully elucidated. Here we report that Notch4 is upregulated in lung tissue from lung cancer patients. Functionally, Hypoxia activates the expressions of Delta-like 4 and Notch4, resulting in the excessive proliferation and migration of LUAD cells as well as apoptotic resistance. Notch4 silencing reduced ERK, JNK, and P38 activation. Meanwhile, Notch4 overexpression enhanced ERK, JNK, and P38 activation in LUAD cells. Furthermore, Notch4 exerted pro-proliferation, anti-apoptosis and pro-migration effects on LUAD cells that were partly reversed by the inhibitors of ERK, JNK, and p38. The binding interaction between Notch4 and ERK/JNK/P38 were confirmed by the co-immunoprecipitation assay. In vivo study revealed that Notch4 played a key role in the growth and metastasis of LUAD using two xenograft models. This study demonstrates that hypoxia activates Notch4-ERK/JNK/P38 MAPK signaling pathways to promote LUAD cell progression and metastasis.Hypoxia contributes to the progression and metastasis of lung adenocarcinoma (LUAD). However, the specific underlying molecular mechanisms have not been fully elucidated. Here we report that Notch4 is upregulated in lung tissue from lung cancer patients. Functionally, Hypoxia activates the expressions of Delta-like 4 and Notch4, resulting in the excessive proliferation and migration of LUAD cells as well as apoptotic resistance. Notch4 silencing reduced ERK, JNK, and P38 activation. Meanwhile, Notch4 overexpression enhanced ERK, JNK, and P38 activation in LUAD cells. Furthermore, Notch4 exerted pro-proliferation, anti-apoptosis and pro-migration effects on LUAD cells that were partly reversed by the inhibitors of ERK, JNK, and p38. The binding interaction between Notch4 and ERK/JNK/P38 were confirmed by the co-immunoprecipitation assay. In vivo study revealed that Notch4 played a key role in the growth and metastasis of LUAD using two xenograft models. This study demonstrates that hypoxia activates Notch4-ERK/JNK/P38 MAPK signaling pathways to promote LUAD cell progression and metastasis.
Hypoxia contributes to the progression and metastasis of lung adenocarcinoma (LUAD). However, the specific underlying molecular mechanisms have not been fully elucidated. Here we report that Notch4 is upregulated in lung tissue from lung cancer patients. Functionally, Hypoxia activates the expressions of Delta-like 4 and Notch4, resulting in the excessive proliferation and migration of LUAD cells as well as apoptotic resistance. Notch4 silencing reduced ERK, JNK, and P38 activation. Meanwhile, Notch4 overexpression enhanced ERK, JNK, and P38 activation in LUAD cells. Furthermore, Notch4 exerted pro-proliferation, anti-apoptosis and pro-migration effects on LUAD cells that were partly reversed by the inhibitors of ERK, JNK, and p38. The binding interaction between Notch4 and ERK/JNK/P38 were confirmed by the co-immunoprecipitation assay. In vivo study revealed that Notch4 played a key role in the growth and metastasis of LUAD using two xenograft models. This study demonstrates that hypoxia activates Notch4-ERK/JNK/P38 MAPK signaling pathways to promote LUAD cell progression and metastasis.
Hypoxia contributes to the progression and metastasis of lung adenocarcinoma (LUAD). However, the specific underlying molecular mechanisms have not been fully elucidated. Here we report that Notch4 is upregulated in lung tissue from lung cancer patients. Functionally, Hypoxia activates the expressions of and Notch4, resulting in the excessive proliferation and migration of LUAD cells as well as apoptotic resistance. Notch4 silencing reduced ERK, JNK, and P38 activation. Meanwhile, Notch4 overexpression enhanced ERK, JNK, and P38 activation in LUAD cells. Furthermore, Notch4 exerted pro-proliferation, anti-apoptosis and pro-migration effects on LUAD cells that were partly reversed by the inhibitors of ERK, JNK, and p38. The binding interaction between Notch4 and ERK/JNK/P38 were confirmed by the co-immunoprecipitation assay. study revealed that Notch4 played a key role in the growth and metastasis of LUAD using two xenograft models. This study demonstrates that hypoxia activates Notch4-ERK/JNK/P38 MAPK signaling pathways to promote LUAD cell progression and metastasis.
Hypoxia contributes to the progression and metastasis of lung adenocarcinoma (LUAD). However, the specific underlying molecular mechanisms have not been fully elucidated. Here we report that Notch4 is upregulated in lung tissue from lung cancer patients. Functionally, Hypoxia activates the expressions of Delta-like 4 and Notch4, resulting in the excessive proliferation and migration of LUAD cells as well as apoptotic resistance. Notch4 silencing reduced ERK, JNK, and P38 activation. Meanwhile, Notch4 overexpression enhanced ERK, JNK, and P38 activation in LUAD cells. Furthermore, Notch4 exerted pro-proliferation, anti-apoptosis and pro-migration effects on LUAD cells that were partly reversed by the inhibitors of ERK, JNK, and p38. The binding interaction between Notch4 and ERK/JNK/P38 were confirmed by the co-immunoprecipitation assay. In vivo study revealed that Notch4 played a key role in the growth and metastasis of LUAD using two xenograft models. This study demonstrates that hypoxia activates Notch4-ERK/JNK/P38 MAPK signaling pathways to promote LUAD cell progression and metastasis.
Author Li, Xiaochen
Cao, Xiaopei
He, Yuanzhou
Liu, Xiansheng
Zhao, Hanqiu
Li, Ke
Qin, Lu
Guo, Mingzhou
Fang, Xiaoyu
AuthorAffiliation 2 Key Laboratory of Respiratory Diseases, National Ministry of Health of the People’s Republic of China and National Clinical Research Center for Respiratory Disease , Wuhan , China
1 Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China
3 Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China
AuthorAffiliation_xml – name: 1 Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China
– name: 2 Key Laboratory of Respiratory Diseases, National Ministry of Health of the People’s Republic of China and National Clinical Research Center for Respiratory Disease , Wuhan , China
– name: 3 Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China
Author_xml – sequence: 1
  givenname: Xiaochen
  surname: Li
  fullname: Li, Xiaochen
– sequence: 2
  givenname: Xiaopei
  surname: Cao
  fullname: Cao, Xiaopei
– sequence: 3
  givenname: Hanqiu
  surname: Zhao
  fullname: Zhao, Hanqiu
– sequence: 4
  givenname: Mingzhou
  surname: Guo
  fullname: Guo, Mingzhou
– sequence: 5
  givenname: Xiaoyu
  surname: Fang
  fullname: Fang, Xiaoyu
– sequence: 6
  givenname: Ke
  surname: Li
  fullname: Li, Ke
– sequence: 7
  givenname: Lu
  surname: Qin
  fullname: Qin, Lu
– sequence: 8
  givenname: Yuanzhou
  surname: He
  fullname: He, Yuanzhou
– sequence: 9
  givenname: Xiansheng
  surname: Liu
  fullname: Liu, Xiansheng
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34988077$$D View this record in MEDLINE/PubMed
BookMark eNp1kktvEzEUhUeoiJbSH8AGeckmiV8ztjdIUVVoSVoiHhI7y2N7Jq4mdrCdQPj1OE2LWiQkS7buPfe7ks95WR354G1VvUZwTAgXk07bYRhjiNGYcYgweladYCyaUUPo96NH7-PqLKVbCIumZjUnL6pjQgXnkLGT6vflbh1-OQWmOrutyjaBm5D1koJtKV58nk0-3swmC8LB9XQxA19c79XgfA8WKi9_ql0COYBFDKuQLZhvSmNqrA9aRe18WKl9r482JRc8UN6Aa5tVKselV9XzTg3Jnt3fp9W39xdfzy9H808frs6n85GmTZ1HqG0awjuqKe2QbS1uaacVN4pzI7DB2takblHHdIcZroVBUAshoBI1agxE5LS6OnBNULdyHd1KxZ0Mysm7Qoi9VDE7PVgpulazBhoGbUepUKJtuOVIM0gE5ZYU1rsDa71pV9Zo63NUwxPo0453S9mHreQMIwRhAby9B8TwY2NTliuX9k4qb8MmSdwghotLrCnSN493_V3yYF4RsINAx5BStJ3ULqtcfrqsdoNEUO6TIu-SIvdJkYeklEn0z-QD_P8zfwD7xsKq
CitedBy_id crossref_primary_10_1038_s12276_022_00867_0
crossref_primary_10_3892_mmr_2024_13392
crossref_primary_10_3389_fphar_2024_1439497
crossref_primary_10_3389_fonc_2023_1078768
crossref_primary_10_3390_life15030396
crossref_primary_10_1016_j_canlet_2024_216647
crossref_primary_10_4103_1673_5374_346460
crossref_primary_10_1016_j_mito_2023_09_001
crossref_primary_10_3390_biom14121581
crossref_primary_10_3390_ijms24087502
crossref_primary_10_1016_j_heliyon_2023_e15805
crossref_primary_10_1007_s11626_023_00768_0
crossref_primary_10_1007_s11356_024_32746_8
Cites_doi 10.1016/j.devcel.2011.06.017
10.1158/1078-0432.Ccr-12-3696
10.1158/1078-0432.Ccr-14-2808
10.1038/nm0897-917
10.1093/jnci/92.16.1355
10.1016/j.ccr.2012.07.016
10.1016/s1535-6108(03)00085-0
10.1038/s41388-021-02097-6
10.1088/0026-1394/47/1/L01
10.1002/med.21264
10.1111/j.1440-1827.1997.tb04525.x
10.1159/000024506
10.1016/j.cell.2011.02.013
10.1002/jcp.28993
10.1073/pnas.0802047105
10.1002/path.1400
10.1186/s12951-020-00735-x
10.1146/annurev-biophys-101920-082204
10.1007/s00204-015-1472-2
10.3389/fcell.2021.630678
10.1111/jcmm.17040
10.7150/jca.26359
10.3390/cancers11101618
10.1016/j.trecan.2019.08.005
10.1016/j.semcancer.2015.02.006
10.1152/ajplung.00281.2009
10.1073/pnas.102660199
10.1126/science.284.5415.770
10.1158/0008-5472.Can-08-4021
10.1042/cs20201500
10.3389/fonc.2021.741326
10.1158/1535-7163.Mct-05-0082
10.7150/thno.38875
10.1016/j.yexcr.2017.04.030
10.1016/j.neulet.2019.134624
10.1152/jn.00170.2010
10.1073/pnas.011530298
10.1371/journal.pone.0118201
10.1016/s1534-5807(02)00189-2
10.1186/s13046-019-1463-x
10.1016/j.pharmthera.2016.04.009
10.1016/j.phymed.2021.153564
10.1007/s12032-016-0747-7
10.1038/25141
10.1152/physrev.00005.2017
10.1161/CIRCRESAHA.108.174318
10.1002/ijc.10329
10.1016/s1534-5807(01)00105-8
10.1016/j.cell.2012.08.029
10.1002/ctm2.349
10.1016/j.bcp.2021.114622
10.2174/092986712801661040
10.1016/j.trecan.2016.10.016
10.1007/s10495-017-1368-0
10.1210/er.2016-1002
10.1007/978-1-4614-5915-6_9
10.1016/j.critrevonc.2021.103403
10.1038/19083
10.1038/onc.2011.467
10.3892/ol.2018.9600
10.1189/jlb.1VMR1216-505R
10.3322/caac.21442
10.1126/science.7878464
10.3389/fonc.2014.00345
10.3892/or.2016.5211
10.1016/j.cell.2016.11.037
ContentType Journal Article
Copyright Copyright © 2021 Li, Cao, Zhao, Guo, Fang, Li, Qin, He and Liu.
Copyright © 2021 Li, Cao, Zhao, Guo, Fang, Li, Qin, He and Liu. 2021 Li, Cao, Zhao, Guo, Fang, Li, Qin, He and Liu
Copyright_xml – notice: Copyright © 2021 Li, Cao, Zhao, Guo, Fang, Li, Qin, He and Liu.
– notice: Copyright © 2021 Li, Cao, Zhao, Guo, Fang, Li, Qin, He and Liu. 2021 Li, Cao, Zhao, Guo, Fang, Li, Qin, He and Liu
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fcell.2021.780121
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Li et al
EISSN 2296-634X
ExternalDocumentID oai_doaj_org_article_9fbc760d70ef449a9b68e81c703948e3
PMC8721100
34988077
10_3389_fcell_2021_780121
Genre Journal Article
GrantInformation_xml – fundername: ;
GroupedDBID 53G
5VS
9T4
AAFWJ
AAYXX
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RPM
EMOBN
IAO
IEA
IHR
IHW
IPNFZ
ISR
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c465t-1b6638f4c44f1ebe2b4fca8da88d92d2ce535b1f7cf27259d10c9990a9516d013
IEDL.DBID M48
ISSN 2296-634X
IngestDate Wed Aug 27 01:31:51 EDT 2025
Thu Aug 21 18:12:27 EDT 2025
Fri Jul 11 02:22:12 EDT 2025
Thu Jan 02 22:56:38 EST 2025
Tue Jul 01 01:17:01 EDT 2025
Thu Apr 24 22:58:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Notch4
mitogen-activated protein kinase
hypoxia
proliferation
lung adenocarcinoma
migration
apoptosis
Language English
License Copyright © 2021 Li, Cao, Zhao, Guo, Fang, Li, Qin, He and Liu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-1b6638f4c44f1ebe2b4fca8da88d92d2ce535b1f7cf27259d10c9990a9516d013
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Rita Fior, Champalimaud Foundation, Portugal
Edited by: João Pessoa, University of Coimbra, Portugal
Jie Li, Chinese Academy of Medical Sciences and Peking Union Medical College, China
These authors have contributed equally to this work
Reviewed by: Dong Liang, Shandong University, China
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Cell and Developmental Biology
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fcell.2021.780121
PMID 34988077
PQID 2617275876
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_9fbc760d70ef449a9b68e81c703948e3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8721100
proquest_miscellaneous_2617275876
pubmed_primary_34988077
crossref_citationtrail_10_3389_fcell_2021_780121
crossref_primary_10_3389_fcell_2021_780121
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-20
PublicationDateYYYYMMDD 2021-12-20
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-20
  day: 20
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in cell and developmental biology
PublicationTitleAlternate Front Cell Dev Biol
PublicationYear 2021
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Ye (B58) 2019; 17
Shin (B43) 2021
Imielinski (B19) 2012; 150
Mennerich (B35) 2019; 5
Fu (B14) 2021
Siegel (B46) 2018; 68
Li (B33) 2016; 33
Rödel (B40) 2012; 19
Suzuki (B50) 1998; 18
Wei (B54) 2010; 298
Zhou (B65) 2020; 10
Li (B32) 2021; 11
Yang (B57) 2017; 37
Yen (B60) 2015; 21
Zhang (B63) 2021; 9
Kwak (B28) 2021; 86
Zhong (B64) 2021; 135
Ayaz (B4) 2014; 4
Thompson (B52) 1995; 267
Zou (B66) 2019; 38
Zhang (B62) 2017; 22
Byun (B6) 2013; 19
Domingo-Domenech (B11) 2012; 22
Rao (B39) 2005; 4
Kim (B25) 2015; 89
Landor (B30) 2017; 356
Cao (B7) 2020; 235
Irshad (B20) 2015; 10
De Strooper (B9) 1999; 398
Shu (B44) 2021; 19
Aggarwal (B1) 2021; 164
Kiec-Wilk (B24) 2010; 61
Martinou (B34) 2011; 21
Feitelson (B12) 2015; 35
Pennacchietti (B37) 2003; 3
Hu (B17) 2021; 190
Braicu (B5) 2019; 11
Qin (B38) 2020; 715
Siebel (B45) 2017; 97
Grazioli (B15) 2017; 102
Kodate (B26) 1997; 47
Hanahan (B16) 2011; 144
Wigerup (B55) 2016; 164
Krishnamachary (B27) 2003; 63
Niessen (B36) 2008; 102
Taiakina (B51) 2014; 772
Lambert (B29) 2017; 168
Sprinzak (B47) 2021; 50
Francis (B13) 2002; 3
Hu (B18) 2002; 2
Zanotti (B61) 2016; 37
Schito (B42) 2016; 2
Ambrosini (B2) 1997; 3
Ding (B10) 2012; 31
Wu (B56) 2018; 9
Yeh (B59) 2009; 69
Li (B31) 1998; 396
Vihinen (B53) 2002; 99
Sahlgren (B41) 2008; 105
Dang (B8) 2000; 92
Kanwar (B23) 2013; 33
Stamenkovic (B48) 2003; 200
Artavanis-Tsakonas (B3) 1999; 284
Jögi (B22) 2002; 99
Jain (B21) 2021; 11
Struhl (B49) 2001; 98
References_xml – volume: 21
  start-page: 92
  year: 2011
  ident: B34
  article-title: Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics
  publication-title: Develop. Cel
  doi: 10.1016/j.devcel.2011.06.017
– volume: 19
  start-page: 3894
  year: 2013
  ident: B6
  article-title: USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.Ccr-12-3696
– volume: 21
  start-page: 2084
  year: 2015
  ident: B60
  article-title: Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.Ccr-14-2808
– volume: 3
  start-page: 917
  year: 1997
  ident: B2
  article-title: A Novel Anti-apoptosis Gene, Survivin, Expressed in Cancer and Lymphoma
  publication-title: Nat. Med.
  doi: 10.1038/nm0897-917
– volume: 92
  start-page: 1355
  year: 2000
  ident: B8
  article-title: Chromosome 19 Translocation, Overexpression of Notch3, and Human Lung Cancer
  publication-title: JNCI J. Natl. Cancer Inst.
  doi: 10.1093/jnci/92.16.1355
– volume: 22
  start-page: 373
  year: 2012
  ident: B11
  article-title: Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.07.016
– volume: 3
  start-page: 347
  year: 2003
  ident: B37
  article-title: Hypoxia Promotes Invasive Growth by Transcriptional Activation of the Met Protooncogene
  publication-title: Cancer Cell
  doi: 10.1016/s1535-6108(03)00085-0
– year: 2021
  ident: B43
  article-title: Oncogenic KRAS Promotes Growth of Lung Cancer Cells Expressing SLC3A2-NRG1 Fusion via ADAM17-Mediated Shedding of NRG1
  publication-title: Oncogene
  doi: 10.1038/s41388-021-02097-6
– volume: 63
  start-page: 1138
  year: 2003
  ident: B27
  article-title: Regulation of colon Carcinoma Cell Invasion by Hypoxia-Inducible Factor 1
  publication-title: Cancer Res.
  doi: 10.1088/0026-1394/47/1/L01
– volume: 33
  start-page: 765
  year: 2013
  ident: B23
  article-title: Survivin Signaling in Clinical Oncology: A Multifaceted Dragon
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.21264
– volume: 47
  start-page: 461
  year: 1997
  ident: B26
  article-title: Expression of Matrix Metalloproteinase (Gelatinase) in T1 Adenocarcinoma of the Lung
  publication-title: Pathol. Int.
  doi: 10.1111/j.1440-1827.1997.tb04525.x
– volume: 18
  start-page: 134
  year: 1998
  ident: B50
  article-title: Expression of Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinases in Non-Small-Cell Lung Cancer
  publication-title: Invasion Metastasis
  doi: 10.1159/000024506
– volume: 144
  start-page: 646
  year: 2011
  ident: B16
  article-title: Hallmarks of Cancer: The Next Generation
  publication-title: Cell
  doi: 10.1016/j.cell.2011.02.013
– volume: 235
  start-page: 538
  year: 2020
  ident: B7
  article-title: TRB3 Interacts with ERK and JNK and Contributes to the Proliferation, Apoptosis, and Migration of Lung Adenocarcinoma Cells
  publication-title: J. Cel Physiol
  doi: 10.1002/jcp.28993
– volume: 105
  start-page: 6392
  year: 2008
  ident: B41
  article-title: Notch Signaling Mediates Hypoxia-Induced Tumor Cell Migration and Invasion
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.0802047105
– volume: 200
  start-page: 448
  year: 2003
  ident: B48
  article-title: Extracellular Matrix Remodelling: The Role of Matrix Metalloproteinases
  publication-title: J. Pathol.
  doi: 10.1002/path.1400
– volume: 19
  start-page: 4
  year: 2021
  ident: B44
  article-title: Hyaluronic Acid Modified Covalent Organic Polymers for Efficient Targeted and Oxygen-Evolved Phototherapy
  publication-title: J. Nanobiotechnol
  doi: 10.1186/s12951-020-00735-x
– volume: 50
  start-page: 157
  year: 2021
  ident: B47
  article-title: Biophysics of Notch Signaling
  publication-title: Annu. Rev. Biophys.
  doi: 10.1146/annurev-biophys-101920-082204
– volume: 89
  start-page: 867
  year: 2015
  ident: B25
  article-title: Compromised MAPK Signaling in Human Diseases: An Update
  publication-title: Arch. Toxicol.
  doi: 10.1007/s00204-015-1472-2
– volume: 9
  start-page: 630678
  year: 2021
  ident: B63
  article-title: SP600125, a JNK-Specific Inhibitor, Regulates In Vitro Auricular Cartilage Regeneration by Promoting Cell Proliferation and Inhibiting Extracellular Matrix Metabolism
  publication-title: Front. Cel Dev. Biol.
  doi: 10.3389/fcell.2021.630678
– year: 2021
  ident: B14
  article-title: Reticulocalbin 1 Is Required for Proliferation and Migration of Non‐Small Cell Lung Cancer Cells Regulated by Osteoblast‐Conditioned Medium
  publication-title: J. Cel Mol Med
  doi: 10.1111/jcmm.17040
– volume: 9
  start-page: 2374
  year: 2018
  ident: B56
  article-title: NOTCH4 Is a Novel Prognostic Marker that Correlates with Colorectal Cancer Progression and Prognosis
  publication-title: J. Cancer
  doi: 10.7150/jca.26359
– volume: 11
  start-page: 1618
  year: 2019
  ident: B5
  article-title: A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
  publication-title: Cancers
  doi: 10.3390/cancers11101618
– volume: 5
  start-page: 632
  year: 2019
  ident: B35
  article-title: DUBs, Hypoxia, and Cancer
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2019.08.005
– volume: 35
  start-page: S25
  year: 2015
  ident: B12
  article-title: Sustained Proliferation in Cancer: Mechanisms and Novel Therapeutic Targets
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2015.02.006
– volume: 298
  start-page: L863
  year: 2010
  ident: B54
  article-title: JNK Regulates Serotonin-Mediated Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells
  publication-title: Am. J. Physiology-Lung Cell Mol. Physiol.
  doi: 10.1152/ajplung.00281.2009
– volume: 99
  start-page: 7021
  year: 2002
  ident: B22
  article-title: Hypoxia Alters Gene Expression in Human Neuroblastoma Cells Toward an Immature and Neural Crest-Like Phenotype
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.102660199
– volume: 284
  start-page: 770
  year: 1999
  ident: B3
  article-title: Notch Signaling: Cell Fate Control and Signal Integration in Development
  publication-title: Science
  doi: 10.1126/science.284.5415.770
– volume: 69
  start-page: 5039
  year: 2009
  ident: B59
  article-title: The Activated Notch1 Signal Pathway Is Associated with Gastric Cancer Progression through Cyclooxygenase-2
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.Can-08-4021
– volume: 135
  start-page: 847
  year: 2021
  ident: B64
  article-title: EB2 Promotes Hepatocellular Carcinoma Proliferation and Metastasis via MAPK/ERK Pathway by Modulating Microtubule Dynamics
  publication-title: Clin. Sci. (Lond).
  doi: 10.1042/cs20201500
– volume: 11
  start-page: 741326
  year: 2021
  ident: B21
  article-title: Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2021.741326
– volume: 4
  start-page: 1399
  year: 2005
  ident: B39
  article-title: Inhibition of Invasion, Angiogenesis, Tumor Growth, and Metastasis by Adenovirus-Mediated Transfer of Antisense uPAR and MMP-9 in Non-Small Cell Lung Cancer Cells
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.Mct-05-0082
– volume: 10
  start-page: 2405
  year: 2020
  ident: B65
  article-title: NOTCH4 Maintains Quiescent Mesenchymal-Like Breast Cancer Stem Cells via Transcriptionally Activating SLUG and GAS1 in Triple-Negative Breast Cancer
  publication-title: Theranostics
  doi: 10.7150/thno.38875
– volume: 356
  start-page: 146
  year: 2017
  ident: B30
  article-title: The Interplay between the Cellular Hypoxic Response and Notch Signaling
  publication-title: Exp. Cel Res.
  doi: 10.1016/j.yexcr.2017.04.030
– volume: 715
  start-page: 134624
  year: 2020
  ident: B38
  article-title: Notch Activation Enhances Microglial CX3CR1/P38 MAPK Pathway in Rats Model of Vincristine-Induced Peripheral Neuropathy
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2019.134624
– volume: 61
  start-page: 217
  year: 2010
  ident: B24
  article-title: The MAPK-Dependent Regulation of the Jagged/Notch Gene Expression by VEGF, bFGF or PPAR Gamma Mediated Angiogenesis in HUVEC
  publication-title: J. Physiol. Pharmacol.
  doi: 10.1152/jn.00170.2010
– volume: 98
  start-page: 229
  year: 2001
  ident: B49
  article-title: Presenilin-Mediated Transmembrane Cleavage Is Required for Notch Signal Transduction in Drosophila
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.011530298
– volume: 10
  start-page: e0118201
  year: 2015
  ident: B20
  article-title: A Combined Gene Signature of Hypoxia and Notch Pathway in Human Glioblastoma and its Prognostic Relevance
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0118201
– volume: 3
  start-page: 85
  year: 2002
  ident: B13
  article-title: aph-1 and Pen-2 Are Required for Notch Pathway Signaling, γ-Secretase Cleavage of βAPP, and Presenilin Protein Accumulation
  publication-title: Develop. Cel
  doi: 10.1016/s1534-5807(02)00189-2
– volume: 38
  start-page: 456
  year: 2019
  ident: B66
  article-title: NOTCH2 Negatively Regulates Metastasis and Epithelial-Mesenchymal Transition via TRAF6/AKT in Nasopharyngeal Carcinoma
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-019-1463-x
– volume: 164
  start-page: 152
  year: 2016
  ident: B55
  article-title: Therapeutic Targeting of Hypoxia and Hypoxia-Inducible Factors in Cancer
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2016.04.009
– volume: 86
  start-page: 153564
  year: 2021
  ident: B28
  article-title: The 3-Deoxysappanchalcone Induces ROS-Mediated Apoptosis and Cell Cycle Arrest via JNK/p38 MAPKs Signaling Pathway in Human Esophageal Cancer Cells
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2021.153564
– volume: 33
  start-page: 33
  year: 2016
  ident: B33
  article-title: Notch-1 Signaling Activates NF-Κb in Human Breast Carcinoma MDA-MB-231 Cells via PP2A-Dependent AKT Pathway
  publication-title: Med. Oncol.
  doi: 10.1007/s12032-016-0747-7
– volume: 396
  start-page: 580
  year: 1998
  ident: B31
  article-title: Control of Apoptosis and Mitotic Spindle Checkpoint by Survivin
  publication-title: Nature
  doi: 10.1038/25141
– volume: 97
  start-page: 1235
  year: 2017
  ident: B45
  article-title: Notch Signaling in Development, Tissue Homeostasis, and Disease
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00005.2017
– volume: 102
  start-page: 1169
  year: 2008
  ident: B36
  article-title: Notch Signaling in Cardiac Development
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.108.174318
– volume: 99
  start-page: 157
  year: 2002
  ident: B53
  article-title: Matrix Metalloproteinases in Cancer: Prognostic Markers and Therapeutic Targets
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.10329
– volume: 2
  start-page: 69
  year: 2002
  ident: B18
  article-title: Nicastrin Is Required for γ-Secretase Cleavage of the Drosophila Notch Receptor
  publication-title: Develop. Cel
  doi: 10.1016/s1534-5807(01)00105-8
– volume: 150
  start-page: 1107
  year: 2012
  ident: B19
  article-title: Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
  publication-title: Cell
  doi: 10.1016/j.cell.2012.08.029
– volume: 11
  start-page: e349
  year: 2021
  ident: B32
  article-title: Hypoxic Colorectal Cancer‐Derived Extracellular Vesicles Deliver microRNA‐361‐3p to Facilitate Cell Proliferation by Targeting TRAF3 via the Noncanonical NF‐κB Pathways
  publication-title: Clin. Translational Med.
  doi: 10.1002/ctm2.349
– volume: 190
  start-page: 114622
  year: 2021
  ident: B17
  article-title: Malayoside, a Cardenolide Glycoside Extracted from Antiaris Toxicaria Lesch, Induces Apoptosis in Human Non-Small Lung Cancer Cells via MAPK-Nur77 Signaling Pathway
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2021.114622
– volume: 19
  start-page: 3679
  year: 2012
  ident: B40
  article-title: Survivin as a Prognostic/Predictive Marker and Molecular Target in Cancer Therapy
  publication-title: Curr. Med. Chem.
  doi: 10.2174/092986712801661040
– volume: 2
  start-page: 758
  year: 2016
  ident: B42
  article-title: Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2016.10.016
– volume: 22
  start-page: 877
  year: 2017
  ident: B62
  article-title: Notch-4 Silencing Inhibits Prostate Cancer Growth and EMT via the NF-Κb Pathway
  publication-title: Apoptosis
  doi: 10.1007/s10495-017-1368-0
– volume: 37
  start-page: 223
  year: 2016
  ident: B61
  article-title: Notch Signaling and the Skeleton
  publication-title: Endocr. Rev.
  doi: 10.1210/er.2016-1002
– volume: 772
  start-page: 189
  year: 2014
  ident: B51
  article-title: Intratumoral Hypoxia as the Genesis of Genetic Instability and Clinical Prognosis in Prostate Cancer
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-1-4614-5915-6_9
– volume: 164
  start-page: 103403
  year: 2021
  ident: B1
  article-title: NOTCH Signaling: Journey of an Evolutionarily Conserved Pathway in Driving Tumor Progression and its Modulation as a Therapeutic Target
  publication-title: Crit. Rev. Oncology/Hematology
  doi: 10.1016/j.critrevonc.2021.103403
– volume: 398
  start-page: 518
  year: 1999
  ident: B9
  article-title: A Presenilin-1-Dependent γ-Secretase-Like Protease Mediates Release of Notch Intracellular Domain
  publication-title: Nature
  doi: 10.1038/19083
– volume: 31
  start-page: 2899
  year: 2012
  ident: B10
  article-title: Cross-Talk between Endothelial Cells and Tumor via Delta-Like ligand4/Notch/PTEN Signaling Inhibits Lung Cancer Growth
  publication-title: Oncogene
  doi: 10.1038/onc.2011.467
– volume: 17
  start-page: 195
  year: 2019
  ident: B58
  article-title: Puerarin in Inducing Apoptosis of Bladder Cancer Cells through Inhibiting SIRT1/p53 Pathway
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2018.9600
– volume: 102
  start-page: 361
  year: 2017
  ident: B15
  article-title: The Mazy Case of Notch and Immunoregulatory Cells
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.1VMR1216-505R
– volume: 68
  start-page: 7
  year: 2018
  ident: B46
  article-title: Cancer Statistics, 2018
  publication-title: CA: A Cancer J. Clinicians
  doi: 10.3322/caac.21442
– volume: 267
  start-page: 1456
  year: 1995
  ident: B52
  article-title: Apoptosis in the Pathogenesis and Treatment of Disease
  publication-title: Science
  doi: 10.1126/science.7878464
– volume: 4
  start-page: 345
  year: 2014
  ident: B4
  article-title: Non-Canonical Notch Signaling in Cancer and Immunity
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2014.00345
– volume: 37
  start-page: 348
  year: 2017
  ident: B57
  article-title: Hepatitis B Virus X Protein and Hypoxia-Inducible Factor-1α Stimulate Notch Gene Expression in Liver Cancer Cells
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2016.5211
– volume: 168
  start-page: 670
  year: 2017
  ident: B29
  article-title: Emerging Biological Principles of Metastasis
  publication-title: Cell
  doi: 10.1016/j.cell.2016.11.037
SSID ssj0001257583
Score 2.2744892
Snippet Hypoxia contributes to the progression and metastasis of lung adenocarcinoma (LUAD). However, the specific underlying molecular mechanisms have not been fully...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 780121
SubjectTerms apoptosis
Cell and Developmental Biology
hypoxia
lung adenocarcinoma
mitogen-activated protein kinase
Notch4
proliferation
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yIPgiflu_iOCTUDdN0zZ5XOWO5dZdFvXg3kKaj7Wg6XHtqetf7yTZW3ZF9MXXJCUhv8nMb9LJDEKvLJhRRW2ZO2c0OChtkfOK29wqW5Wg_wwV4e3wYlnPztjpeXW-V-orxISl9MBp4ybCtbqpiWmIdYwJJdqaW15okFTBuI15PsHm7TlT6XYFaAgv029M8MLExIWLcPAHafGmCVq5ODBEMV__n0jm77GSe8bn5A66vWWNeJpWexfdsP4eupnqSG7uo5-zzUX_o1N4qmO1MjvgZQ9wMPwNGo8_zCeny_lkVXK8mK7m-GO3DvTbr_EK-N93tRnw2ONVDMyz-D0cfzwFdQRW7lJ3vv-qQt86Bcx6rLzBCzsqoJVDNzxAZyfHn97N8m1RhVyzuhrzogWOwR3TjLkCEKQtc1pxozg3ghqqAaOqLVyjHW3ANzIF0UAiiQIqVhsgjA_Rke-9fYyw4K6Kb3NhGANiwY2udWkNcaRVXLsMkesdlnqbcTwUvvgiwfMIoMgIigygyARKhl7vPrlI6Tb-NvhtgG03MGTKjg0gP3IrP_Jf8pOhl9egSzhZYQ7lbX81SBrJXQXmIkOPkhDspiqZAMXXNBlqDsTjYC2HPb77HLN38-hzkyf_Y_FP0a2wHyG8hpJn6Gi8vLLPgSSN7Yt4Hn4BU1EQMg
  priority: 102
  providerName: Directory of Open Access Journals
Title Hypoxia Activates Notch4 via ERK/JNK/P38 MAPK Signaling Pathways to Promote Lung Adenocarcinoma Progression and Metastasis
URI https://www.ncbi.nlm.nih.gov/pubmed/34988077
https://www.proquest.com/docview/2617275876
https://pubmed.ncbi.nlm.nih.gov/PMC8721100
https://doaj.org/article/9fbc760d70ef449a9b68e81c703948e3
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBelZbCXse7T-yga7GngxpZlW3oYJRstoVlC2BbIm5H1kRk6uYvdrelfv5PshGWEsVdLtmz9dHe_k093CL3VYEYF0UlojJLgoJRxyFKmQy10moD-U4S7s8OTaTaa08tFujhAm_JW_QQ2e107V09qvro6vf2xPgOBf-88TrC3A-P2uMHVI_Fp7hQuOENHYJhyV9Bg0rP9bssFuIlPzEkIz8IsoYvuP-f-p-xYKp_Qfx8L_TuY8g_rdPEQPehpJR526-AYHWj7CN3rCk2uH6O70fq6vq0EHkpfzkw3eFoDXhT_hIvnn8eDy-l4MEsYngxnY_ylWjp-bpd4BgTxl1g3uK3xzEfuafwJ9AMegr4CM7iSla2_C9e27CJqLRZW4YluBfDOpmqeoPnF-dePo7CvuhBKmqVtGJdAQpihklITA8SkpEYKpgRjihNFJICYlrHJpSE5OE8qjiSwzEgAV8sUMMqn6NDWVj9HmDOT-sO70I0C82BKZjLRKjJRKZg0AYo2M1zIPiW5q4xxVYBr4kApPCiFA6XoQAnQu-0t110-jn91_uBg23Z0qbT9hXq1LHrJLLgpZZ5FKo-0oZQLXmZMs1iCKuSU6SRAbzagFyB6bgxhdX3TFMSzvxTsSYCedYtgO1RCOWjGPA9QvrM8dt5lt8VW33x6b-ad8ujFf4z7Et13n-vCa0j0Ch22qxv9GkhSW574zYUTLwC_Af-cEJs
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxia+Activates+Notch4+via+ERK%2FJNK%2FP38+MAPK+Signaling+Pathways+to+Promote+Lung+Adenocarcinoma+Progression+and+Metastasis&rft.jtitle=Frontiers+in+cell+and+developmental+biology&rft.au=Li%2C+Xiaochen&rft.au=Cao%2C+Xiaopei&rft.au=Zhao%2C+Hanqiu&rft.au=Guo%2C+Mingzhou&rft.date=2021-12-20&rft.issn=2296-634X&rft.eissn=2296-634X&rft.volume=9&rft.spage=780121&rft_id=info:doi/10.3389%2Ffcell.2021.780121&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-634X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-634X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-634X&client=summon